Objective: To assess the extent that the genetic and environmental factors contribute to the phenotypic correlations between obesity traits and age at menarche (AAM), and also to examine the influence of AAM on obesity in both pre-and postmenopausal women. Methods: Five hundred and twelve pedigrees with 2667 Caucasian female subjects from two to four generations were recruited. Fat mass and lean mass (both in kg) were measured by dual-energy X-ray absorptiometry scanner. Body mass index (BMI) (kg/m 2 ) was calculated. We performed bivariate quantitative genetic analyses in the total sample containing 2667 Caucasian women. We also selected 206 unrelated premenopausal women and 140 unrelated postmenopausal women from the total sample, and computed the respective phenotypic correlation between obesity and AAM in these two subgroups. Results: For fat mass, lean mass and BMI, we detected their significant negative genetic correlations with AAM after adjustment for significant covariates, which were À0.3170 (Po0.001), À0.1721 (Po0.05) and À0.3665 (Po0.001), respectively. However, their environmental correlations with AAM were all nonsignificant (P40.05), ranging from À0.0016 to 0.0192. In the premenopausal subgroup, significant associations were observed between fat mass and AAM (r ¼ À0.231, Po0.01) as well as between BMI and AAM (r ¼ À0.257, Po0.01). In the postmenopausal subgroup, no such associations were observed. Conclusion: Our results for the first time suggested that significant phenotypic association between obesity phenotypes and AAM is mainly attributable to shared genetic rather than environmental factors, and AAM may have stronger effects on obesity phenotypes in pre-than in postmenopausal women.
Introduction
Menarche is an important developmental milestone in a female's life. It signals the beginning of the ability to reproduce and is associated with the development of secondary sexual characteristics. Age at menarche (AAM) is an important anthropologic parameter for a female that may affect her health in her later life. A number of studies have suggested association between AAM and obesity phenotypes. [1] [2] [3] [4] [5] [6] In a longitudinal study of the northern Finland birth cohort, the proportions of overweight and obese females were significantly higher in those who had earlier menarche. 3 Consistent with that, Wasserman et al. 6 found that early menarcheal ages (o12 years) were associated with the risk for obesity in postmenopausal women. Both obesity phenotypes and AAM are complex traits determined by multiple genetic and environmental factors, with genetic factors playing an important role. The narrowsense heritability (h 2 ) was from 20 to 65% for fat mass, [7] [8] [9] from 52 to 77% for lean mass [9] [10] [11] and from 0.50 to 0.70 for body mass index (BMI). 11, 12 Twin and family studies demonstrated that 46-72% of the variation in menarcheal age was attributed to genetic effects. [13] [14] [15] Although obesity and AAM are highly heritable and phenotypically correlated, it remains unclear whether and to what extent the phenotypic correlation between the two traits is due to shared genetic or shared environmental factors. In the present study, our primary aim is to study the magnitude of the genetic and environmental correlations between these two traits in a large cohort of Caucasian subjects. In addition, we investigated the association between these two traits in pre-and postmenopausal women, respectively.
Materials and methods

Subjects
The study subjects came from an expanding database being created for studies to search for genes underlying the risk to obesity and osteoporosis in the Osteoporosis Research Center (ORC) of Creighton University. The study was approved by the Creighton University Institutional Review Board, and started from 1997. All the study subjects signed informed consent documents before entering the project. All the study subjects were Caucasians of European origin and came from the Midwest of US. Five hundred and twelve pedigrees with 2667 female subjects from two to four generations were recruited and analyzed. Pedigree members were randomly recruited without considering their BMI. We adopted an exclusion criterion that was elaborated elsewhere. 16 
Measurement
Fat mass and lean mass (both in kg) were measured by a Hologic 1000, 2000 þ or 4500 dual-energy X-ray absorptiometry scanner (Hologic Corp., Waltham, MA, USA). All machines were calibrated daily. Members of the same pedigree were usually measured on the same type of machine. The coefficients of variation (CV) for lean mass and fat mass obtained on the Hologic 4500 scanner were 0.7 and 1.2%, respectively. Similar CVs were observed on Hologic 1000 and 2000 þ scanners. Weight (kg) and height (m) were measured using the standard method at the same visit for the fat mass and lean mass measurement. BMI (kg/m 2 ) was calculated as body weight (in kg) divided by the square of height (m). AAM the status of menopause and the history of hormone replacement therapy (HRT) were selfreported with nurse-administered questionnaires. Menopausal status was defined as having had no menses for at least 12 months.
Statistical analyses
The statistical analyses were detailed previously. 17, 18 In brief, univariate and bivariate variance decomposition analyses were performed by Sequential Oligogenic Linkage Analysis Routines (SOLAR, available on http://www.sfbr.org/solar/).
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The univariate variance analyses were performed to estimate the h 2 of the obesity phenotypes and AAM and to screen the effects of covariates on obesity phenotypes in polygenic models. Age, squared age, menopause status and HRT use were assessed as covariates in polygenic models of obesity phenotypes, and significant covariates (Pp0.05) were used to adjust the raw obesity phenotypes in subsequent bivariate quantitative analyses. The potential confounding effects of menopause status and HRT use were adjusted as they generally affect obesity phenotypes in Caucasians. 20 The bivariate quantitative genetic analysis is a powerful method to directly assess the degree of genetic and environmental correlations between pairs of traits. This method decomposes the phenotypic correlations (r P ) between obesity phenotypes and AAM into the portion due to genes shared in common and that due to shared environment. A bivariate phenotype of an individual was first modeled as a linear function of the individual's trait measurements and the matrix of kinship coefficients for relationships among all pairs of individuals in the pedigree. Based on quantitative genetic theories, the phenotypic variance-covariance matrix and its genetic and environmental components were then obtained. From these matrices, r G (genetic correlations) and r E (environmental correlations) were estimated directly. A more detailed explanation of the extension of this methodology to the bivariate application can be found in a previously published work. 21 Using h 2 , r G and r E computed from pedigree data for obesity phenotypes, we can compute the r P between each pair of traits by the following equation 22 :
where h 1 2 and h 2 2 are respective heritabilities of traits 1 and 2.
The significance of r G , r E and r P between any pair of traits is tested using the likelihood ratio statistic. The likelihood ratio statistic approximately follows a w 2 -distribution with the degrees of freedom equal to the number of constrained parameters. In this study, a significant level of 0.05 was adopted. In analyses, outlier data with four standard deviations were removed. Natural logarithm transformation was performed for variables that did not follow the normal distribution. To compare the phenotypic correlation we obtained, we selected 546 founders who have no parent entry into this study and further assessed Pearson correlation in those founders by SPSS for Windows (SPSS Inc., Chicago, IL, USA, version 10.0). Also, we selected 206 unrelated premenopausal women and 140 unrelated postmenopausal women (natural menopause) from the total sample containing 2667 subjects, excluding those who once received HRT. To get more homogenous random samples, only one subject was selected for each subgroup in a single family. If more than one eligible subject is available in each family, for premenopausal women, those with age range 25-40 have priority to be selected; for postmenopausal women, those with age range 55-75 have priority to be selected. Raw obesity phenotypes were adjusted by age for the above two groups of women before computing the phenotypic correlation with AAM. The correlation analysis was performed by SPSS for Windows.
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Results
The descriptive characteristics of the 2667 female subjects are presented in Table 1 . Squared age, menopause status and HRT use were significant covariates for obesity phenotypes (Po0.05) according to polygenic models. After adjusting for significant covariates, h 2 for obesity phenotypes and AAM ranged from 0.48 to 0.78 (Table 1 ). The basic characteristics of the pre-and postmenopausal subgroups are summarized in Table 2 .
The results of the pairwise bivariate analyses are shown in Table 3 . Fat mass, lean mass and BMI are negatively correlated with AAM phenotypically in the total sample (r P ¼ À0.1891 to À0.1122, Po0.001). In the 546 founders, fat mass and BMI are significantly correlated with AAM (r P 0 ¼ À0.0960, Po0.05; r P 0 ¼ À0.1400, Po0.01), whereas the negative association between lean mass and AAM is not significant (r P 0 ¼ À0.0730, P40.05). These results indicate that early AAM is associated with a higher risk of obesity in later life. We also detected significant genetic correlations between obesity phenotypes and AAM (r G ¼ À0.3665 to À0.1721). To quantify the correlation due to the common genetic factors between these traits, we also calculated the bivariate heritability by squaring the genetic correlation. For example, about 10.05% (r G 2 ¼ (À0.3170)
2 ) genetic variance of fat mass is explained by that of AAM. The absolute values of environmental correlations appear to be lower than that of the genetic correlations and were all statistically nonsignificant (P40.05).
To further examine the respective influence of AAM on obesity phenotypes in both pre-and postmenopausal women, we performed Pearson correlation analysis for each group. The results are shown in Table 4 . In the premenopausal group, fat mass and BMI were inversely correlated with AAM (r pre ¼ À0.231 and À0.257, respectively, Po0.01). The correlation between lean mass and AAM was nonsignificant. In the postmenopausal group, no significant correlation was observed between obesity phenotypes and AAM (P40.05).
Discussion
In the current study, we detected significant phenotypic correlations between obesity phenotypes and AAM, which were consistent with the findings of previous studies that early menarcheal ages were associated with obesity later in life. The results obtained in the total sample and founders were quite similar except for the lean mass, which was not significant in the latter. We further investigated the shared genetic and environmental components between obesity phenotypes and AAM. For a large sample of 2667 female subjects from 512 pedigrees, we detected significant genetic correlations between obesity phenotypes and AAM, whereas the respective environmental correlations were all nonsignificant. Hence, our results suggested that the phenotypic correlations between obesity and AAM phenotypes were mainly attributed to genetic factors. To the best of our knowledge, this is the first study reporting a shared genetic component between obesity phenotypes and AAM. Correlations between obesity phenotypes and age at menarche W Wang et al Physiologically, the observed genetic correlation between obesity and AAM is explainable. The onset of menstruation is regulated by hypothalamic-pituitary-gonadal axis and initiated by increased exposure of tissues to estrogen. 23 The women who have earlier menarche may have lower serum concentrations of sex-hormone-binding globulin (SHBG) [24] [25] [26] and higher serum estrodiol during the follicular phase of the menstrual cycle, as compared to the women who have later menarche. 26 On the other hand, low SHBG and high estrogen levels are associated with increased total and central adiposity in women. 20, [27] [28] [29] SHBG is a protein that binds primarily to steroids such as estrogen. As only the unbound steroid fraction is biologically active, SHBG may play an important role in both AAM and obesity through determining the amount of free estrogen. Estrogen can facilitate the storage of body fat by activating fat-storing enzymes, particularly in 'female' areas such as breasts, thighs and buttocks. In addition, reduced postprandial lipid oxidation due to estrodiol was found in a study on premenopausal women. 30 Importantly, a reduction in lipid oxidation is a possible means of adipose tissue gain. 30, 31 Estrogen may also decrease lipolysis in adipose tissues by increasing the number of antilipolytic a2A-adrenergic receptors. 20, 32 Besides, it was suggested that estrogen may attenuate growth hormone (GH) signaling 33 and GH was reported to increase lipid oxidation 34 and reduce body fatness. 35 In sum, estrogen can affect obesity phenotypes through different pathways which may interact with each other, and much work is needed to understand its precise role in obesity. Obesity phenotypes and AAM may share some genes or have closely linked underlying genes, that is, pleiotropy and coincident linkage. 36 Deng et al. 37 found that ER-a gene was associated with BMI variation in healthy Caucasian women. In addition to its role in obesity phenotypes, ER-a plays a distinct physiological role in mediating the specific effects of estrogen on the growth, differentiation and function of reproductive tissues. 38 Therefore, the ER-a gene has been considered as a candidate gene for the onset of menarche, which was substantiated in several studies. 39, 40 Another possible pleiotropic gene is beta 3-AR gene. Mutations in beta 3-AR gene may result in a diminished lipolytic response in adipose tissue and lower resting metabolic rate. 41 According to the hypothesis of Frish and Revelle
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, a lower resting metabolic rate may be a necessary condition to induce menarche. A tryptophan to arginine (Trp64Arg) mutation in the beta 3-AR has been implicated with the genetic predisposition to obesity [43] [44] [45] [46] and earlier menarche 43 as well. Consistent with the results of bivariate quantitative genetic analysis in the total samples, in 207 unrelated premenopausal subjects, fat mass and BMI were negatively correlated with AAM. In contrast to the results of Wasserman et al., 6 in 140 unrelated postmenopausal subjects, we did not find significant correlations between obesity phenotypes and AAM. The results, however, are consistent with the findings of Kirchengast et al., 47 where postmenopausal women exhibited less significant correlation between fat mass and AAM than premenopausal women. During menopause, hormonal changes and several exogenous factors, such as changes in nutritional habits and less physical training, may result in the nonsignificant correlations between obesity phenotypes and AAM in postmenopausal women. 48 The difference of pre-and postmenopausal women in correlation between obesity and AAM may also reflect the limitation of the retrospective method and differential memory vagueness. 47, 49 Notably, lean mass was only significantly associated AAM in the total sample, neither in the 546 founders nor in the pre/postmenopausal subgroups. This discordance may be owing to the different sample size.
A limitation of the current study is the lack of the childhood obesity data. The importance of childhood obesity on the subsequent timing of menarche has been demonstrated in several studies. 2, 4, 50 The higher amount of body fat would act as a secondary hormonal gland influencing estrogen levels during the whole adult life and link with later obesity.
In conclusion, our findings for the first time suggested that the phenotypic correlations between obesity phenotypes and AAM are mainly attributed to genetic factors. In addition, our results demonstrated that AAM may have stronger effects in obesity phenotypes on pre-than in postmenopausal women.
